2026 Annual General Meeting Sydney Australia, 18 September 2026: Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q), the company developing a new class of Synthetic Anti-Infectives, advises that its Annual General Meeting is scheduled for Friday, 6 November 2026, further details of which will be...
2026 Annual General Meeting
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Recce Pharmaceuticals
- Results of General Meeting
- General Meeting Presentation
- Appendix 4E and FY26 Annual Report
- Appendix 4G
- HREC Approves Comparator Study for Pivotal Phase 3 DFI
Later from Recce Pharmaceuticals
- Resolutions under section 249N of the Corporations Act
- Notification of cessation of securities - RCE
- Notice of Annual General Meeting/Proxy Form
- Amendments to Debt Facility with Avenue Capital Group
- Notification regarding unquoted securities - RCE
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals